This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neurology, Other  • Oncology  • Alert me on articles by topic  Social Bookmarking   What's this?

edited by Mark Bernstein, MD, and Mitchel S. Berger, MD, 496 pp, with illus, $169.95, ISBN 978-1-58890-497-3, New York, New York, Thieme, 2008.

John de Groot, MD, Reviewer

Arch Neurol. 2009;66(8):1042-1043.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Neuro-oncologists have witnessed dramatic improvements in our understanding of the biology and treatment of primary brain tumors. The management of patients with primary brain tumor has also improved with advances in neurosurgical and imaging techniques and the use of multimodal therapies. Integration of advanced imaging into surgical planning decreases patient morbidity, and maximal tumor resection is now recognized as playing a central role in improving the overall survival of patients with low- and high-grade gliomas. Since the publication of the first edition of Neuro-Oncology: The Essentials 8 years ago, numerous advances have been made, including the discovery of the importance of glioma cancer stem cells; the molecular classification of glioma tumor subtypes, which may predict outcome; and the confirmation that chemotherapy unequivocally improves the survival of patients with malignant glioma. These advancements, to name only a few, are incorporated into the outstanding second edition of . . . [Full Text of this Article]

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?